Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy
Conclusion:Treatment with DPP-4 inhibitor linagliptin delays the progression of diabetic nephropathy damage in a glucose-independent and blood-pressure-independent manner. The observed effects may be because of the attenuation of podocyte injury and inhibition of myofibroblast transformation.
Source: Journal of Hypertension - Category: Cardiology Tags: ORIGINAL PAPERS: Pathophysiological aspects Source Type: research
More News: Cardiology | Diabetes | Diabetes Type 2 | Enalapril | Endocrinology | Glomeruli | Hypertension | Study | Urology & Nephrology